Unlocking Depression: New CBD Breakthrough Offers Hope Major depressive disorder (MDD) is the psychiatric disease with the highest global prevalence, affecting countless individuals’ social functioning and diminishing their quality of life. As scientists seek new therapeutic targets, the potential role of the endocannabinoid system in MDD offers exciting possibilities. Recent Read more…
The novel study conducted by the Princess Mother National Institute on Drug Abuse Treatment (PMNIDAT) in Thailand has led to promising advances in understanding the efficacy of pharmacological treatments for cannabis-induced psychosis (CIP). With cannabis use becoming increasingly prevalent worldwide, the revelation of these findings offers renewed hope for effective Read more…
Trauma Alert: The Hidden Link to Depression and Addiction in Young People Trauma, depression, and substance abuse are significant challenges facing young people today, particularly among marginalized groups. This article delves into recent research, exploring how these problems are interconnected and evolve over time. Understanding the Impact of Trauma on Read more…
Discover How CBD is Revolutionizing Psychosis Prevention: New Study Reveals Promising Results! In a groundbreaking study, researchers have discovered exciting new evidence on the impact of Cannabidiol (CBD) in preventing psychosis. As a non-intoxicating component of cannabis, CBD shows anxiolytic and antipsychotic properties, alongside a strong safety profile, making it Read more…
Recent research has highlighted the significant therapeutic potential of Cannabidiol (CBD) in managing social stress and enhancing emotional support among patients. This summary delves into the comprehensive study published in the National Center for Biotechnology Information (NCBI), which investigates how CBD interacts with our mental health, particularly in the context Read more…
Exploring the Use of Cannabinoids for Mood Disorders, Anxiety, and PTSD In recent years, the potential therapeutic properties of cannabinoids have garnered significant interest within the medical community, particularly in their potential to treat various psychological conditions. A systematic review published in the National Library of Medicine delves deeply into Read more…
In recent years, the discovery and characterization of novel pathways contributing to neural stem cell (NSC) regulation and the promotion of neurogenesis in the adult hippocampus have been areas of intense research. The article titled “Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis”, published Read more…
Did you know that cannabidiol (CBD) holds potential as a treatment for mood disorders? A systematic review titled “Cannabidiol as a Treatment for Mood Disorders: A Comprehensive Review” sheds light on the therapeutic benefits of CBD in managing mood-related conditions. With an analysis of numerous scientific studies, this review provides Read more…
With a year like 2020 and 2021, it’s little wonder that people are turning to cannabidiol (CBD), known for its calming effects, at higher rates to help with their anxiety surrounding Covid-19. Thirty-nine percent of CBD users recently reported that they were using CBD products more as a result of Read more…
Cannabidiol as a Potential Treatment for Anxiety Disorders Today, anxiety disorders are the most common of mental disorders and affect nearly 30% of adults at some point in their lives. Anxiety statistics worldwide show that anxiety disorders are common across the globe. According to the World Health Organization, 3.6 percent — or about 264 million individuals worldwide — have an anxiety disorder. Additionally, 4.6 percent of females and 2.6 percent of Read more…